NASDAQ: COYACoya Therapeutics Inc Stock Ownership - Who owns Coya Therapeutics?
Insider buying vs selling
Have Coya Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David S. Snyder | Chief Financial Officer | 2024-11-14 | 1,800 | $7.19 | $12.93kBuy |
| Arun Swaminathan | Chief Executive Officer | 2024-11-13 | 5,000 | $7.36 | $36.80kBuy |
| Fred Grossman | Chief Medical Officer | 2024-11-11 | 2,710 | $7.37 | $19.97kBuy |
| Arun Swaminathan | Chief Executive Officer | 2024-11-11 | 5,000 | $7.34 | $36.69kBuy |
COYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when COYA insiders and whales buy or sell their stock.
COYA Shareholders
What type of owners hold Coya Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dme Capital Management LP | 9.84% | 1,646,440 | $10.03M | Institution |
| Aigh Capital Management LLC | 7.08% | 1,183,780 | $7.21M | Institution |
| Howard Berman | 5.68% | 949,338 | $5.78M | Insider |
| Bertex LLC | 5.62% | 939,338 | $5.72M | Insider |
| Vanguard Group Inc | 5.03% | 840,471 | $5.12M | Institution |
| CM Management LLC | 1.20% | 200,000 | $1.22M | Institution |
| Dauntless Investment Group LLC | 1.00% | 167,378 | $1.02M | Institution |
| Wilbur L. Ross Jr. | 0.99% | 165,016 | $1.00M | Insider |
| Geode Capital Management LLC | 0.93% | 155,829 | $949.00k | Institution |
| Blackrock Inc | 0.50% | 83,795 | $510.31k | Institution |
COYA vs Biotech Stocks
Coya Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.